PubHawk
J Clin Oncol March 2023 PMID 36657089

Preoperative Chemotherapy for Operable Colon Cancer: Mature Results of an International Randomized Controlled Trial.

Dion Morton, Matthew Seymour, Laura Magill, Kelly Handley, James Glasbey, Bengt Glimelius, Andy Palmer, Jenny Seligmann, Søren Laurberg, Keigo Murakami, Nick West, Philip Quirke, Richard Gray

Download social card

Mentions

281
Peak: 46 in Jan 2023
across 4 sources since Jan 2023

Extended reach

795,198
potential audience

Total likes

1,011

Video views

35,790

Mentions per month

Jan 2023 – Jul 2025

Where it's discussed

  • X / Twitter139 posts
  • News135 articles
  • Blogs5 articles
  • YouTube2 videos

AI synopsis

What people are saying

Several discussions emphasize the FOxTROT trial's promising outcomes, such as mentions of improved disease control rates and reduced recurrence risks. Phrases like 'excellent results' and 'better disease control at 2 years' convey a tone of enthusiasm and urgency, strengthening the perception of the study's relevance and importance within the oncology community.

AgreementStrong agreement

The discussions consistently express strong support for the findings, with multiple users highlighting the effectiveness of preoperative chemotherapy.

InterestHigh interest

There is a high level of curiosity about the study's details and implications, as many participants ask questions and share resources related to the research.

EngagementHigh engagement

Contributors delve deep into the study's methodology and results, often referencing the specific impacts of neoadjuvant chemotherapy on patient outcomes.

ImpactHigh impact

The overall sentiment is that the study has significant implications for cancer treatment, with discussions containing phrases like 'game changer' and 'transformative'.

Abstract in brief

  • Neoadjuvant chemotherapy (NAC) for locally advanced colon cancer was tested to see if it offers benefits over standard postoperative treatment, with a focus on how it affects disease recurrence and surgical outcomes.
  • In a study of 699 patients, those receiving 6 weeks of NAC before surgery showed improved rates of downstaging, tumor regression, and fewer cases of residual disease compared to the control group who had 24 weeks of chemotherapy after surgery.
  • While NAC was found to be safe and effective in reducing postoperative complications, the addition of the drug panitumumab did not provide additional benefits, especially in patients with tumors that have specific genetic characteristics.
Read the full abstract

Top posts

Most liked on X and Bluesky
Arndt Vogel
@ArndtVogel · X

Mar 9, 2023 · 54 likes · 21 shares · 8,659 followers View post →
Journal of Clinical Oncology
@JCO_ASCO · X

Preoperative chemotherapy for operable #ColonCancer in the @FoxtrotStudy is safe and yields: ⬆️ histopathologic downstaging

Feb 7, 2023 · 33 likes · 12 shares · 54,542 followers View post →
Journal of Clinical Oncology
@JCO_ASCO · X

Jun 24, 2023 · 26 likes · 11 shares · 54,542 followers View post →
Grupo Español de Tratamiento de Tumores Digestivos
@GrupoTTD · X

Nov 6, 2023 · 24 likes · 13 shares · 1,517 followers View post →
European Society of Coloproctology
@escp_tweets · X

Another benefit of the FOxTROT study is that we saw that patients with MMRd do not respond to neoadjuvant chemo, but actually need immunotherapy.  Find out more: https://t.co/w5wr5KADCK Read the paper: https://t.co/wegcXAtvRl #SoMe4Surgery #ColonCancer #ColorectalSurgery https://t.co/xGsqJFMB2o

Apr 5, 2023 · 21 likes · 14 shares · 14,949 followers View post →
Ryan Nipp, MD, MPH, MBA, FASCO
@RyanNipp · X

Preoperative Chemotherapy for Operable Colon #Cancer: Mature Results of an International Randomized Controlled Trial. https://t.co/lutohxTwy2 #GI23 #ColonCancer @ASCO @JCO_ASCO https://t.co/fSf8cItgCB

Jan 19, 2023 · 18 likes · 4 shares · 4,548 followers View post →

All mentions

neco
@NecoNecmi1562 · X

https://t.co/9vVBRpPRED

Jul 18, 2025 · 1,201 followers View post →
Sergio Casillas
@scasillasmd · X

RT @ArndtVogel:

Mar 14, 2024 · 21 shares · 104 followers View post →
Coloproctología_HUCA
@ColoproctoHUCA · X

RT @GrupoTTD:

Feb 7, 2024 · 13 shares · 292 followers View post →
Paula Jimenez Fonseca
@PaulaJFonseca · X

RT @GrupoTTD:

Feb 6, 2024 · 13 shares · 1,834 followers View post →
Eva Ruiz Hispán
@EvaRuizHispan · X

RT @JenSeligmann:

Feb 6, 2024 · 133 shares · 48 followers View post →
Eva Ruiz Hispán
@EvaRuizHispan · X

RT @GrupoTTD:

Feb 6, 2024 · 13 shares · 48 followers View post →
Nieves Martinez Lago MD PhD
@DraMartinezLago · X

RT @GrupoTTD:

Nov 11, 2023 · 13 shares · 2,300 followers View post →
Daniela Roa
@DanielaRoa · X

RT @GrupoTTD:

Nov 6, 2023 · 13 shares · 399 followers View post →
Unidad de Coloproctología del HUGetafe
@ColonGetafe · X

RT @GrupoTTD:

Nov 6, 2023 · 13 shares · 1,185 followers View post →
Maria Eugenia Manrique Acevedo
@eugeniamanri · X

RT @GrupoTTD:

Nov 6, 2023 · 13 shares · 418 followers View post →
AntonioAGR
@aantonioagr · X

RT @GrupoTTD:

Nov 6, 2023 · 13 shares · 330 followers View post →
Pablo Martin
@Pablanza · X

RT @GrupoTTD:

Nov 6, 2023 · 13 shares · 230 followers View post →
Grupo R Comunicación
@GrupoRComunica · X

RT @GrupoTTD:

Nov 6, 2023 · 13 shares · 179 followers View post →
Ana Fernández Montes, MD,Phd
@afm1003 · X

RT @GrupoTTD:

Nov 6, 2023 · 13 shares · 730 followers View post →
Grupo Español de Tratamiento de Tumores Digestivos
@GrupoTTD · X

Nov 6, 2023 · 24 likes · 13 shares · 1,517 followers View post →
Simon P Bach
@Bach_Surgeon · X

Great post @JohnRTMonsonMD we are certainly treating more colon cancer patients using the @FoxtrotStudy protocol after excellent results at 2 years. Results are open access in @JCO_ASCO for those who have not seen it yet https://t.co/mbuZxf4SyM https://t.co/EiK3uynCsA

Oct 13, 2023 · 2 likes · 1,026 followers View post →
Cristiano Argenti
@ArgentiCris · X

RT @JCO_ASCO:

Jun 24, 2023 · 11 shares · 18 followers View post →
Dr. Poetic
@Dr_Doc_ · X

RT @JCO_ASCO:

Jun 24, 2023 · 11 shares · 3,026 followers View post →
Journal of Clinical Oncology
@JCO_ASCO · X

Jun 24, 2023 · 26 likes · 11 shares · 54,542 followers View post →
Birmingham Clinical Trials Unit
@BhamCTU · X

Published in @JCO_ASCO, FOxTROT showed that six weeks of preoperative chemotherapy for operable colon cancer can be delivered safely and provides better 2-year disease control #ICTD2023 https://t.co/8P6KCnqqpq

May 19, 2023 · 1,126 followers View post →
Чиж
@rough_fiddle · X

@OncBrothers @CathyEngMD @OncoAlert @OncoJurdi @pashtoonkasi @SKamath_MD @GIcancerDoc @TumorBoardTues @RenoHemonc @BijoyTelivala @CCAlliance @ThanksCancer @manjuggm @dr_yakupergun @SyedMAhmedMDPhD @ArndtVogel @HosseinTaghiz11 @HemOncFellows @IbrahimSahinMD1 @Jcj84Jeremy Thanks for wonderful scheme! What do You think about pre-operative therapy of colon cancer? (I mean FOxTROT trial (https://t.co/fTx4Bzpz8R)

May 10, 2023 · 1 like · 9 followers View post →
Marta Vallejo Cirujana
@vallejomarta · X

RT @escp_tweets: Response to neoadjuvant #chemotherapy will potentially be used as a marker to decide who needs adjuvant therapy after surg…

Apr 7, 2023 · 11 shares · 361 followers View post →
Miguel F. Cunha
@MiguelCunhaSurg · X

RT @escp_tweets: Response to neoadjuvant #chemotherapy will potentially be used as a marker to decide who needs adjuvant therapy after surg…

Apr 7, 2023 · 11 shares · 994 followers View post →
Mahwish
@mah_surg · X

RT @escp_tweets: Response to neoadjuvant #chemotherapy will potentially be used as a marker to decide who needs adjuvant therapy after surg…

Apr 7, 2023 · 11 shares · 124 followers View post →
Dr Celestino Gutiérrez González MD
@CelestinoGutirr · X

RT @escp_tweets: Response to neoadjuvant #chemotherapy will potentially be used as a marker to decide who needs adjuvant therapy after surg…

Apr 7, 2023 · 11 shares · 11,285 followers View post →
Jarredondo
@jarredondoleon · X

RT @escp_tweets: Response to neoadjuvant #chemotherapy will potentially be used as a marker to decide who needs adjuvant therapy after surg…

Apr 7, 2023 · 11 shares · 307 followers View post →
Steven D Wexner MD, PhD
@SWexner · X

RT @escp_tweets: Response to neoadjuvant #chemotherapy will potentially be used as a marker to decide who needs adjuvant therapy after surg…

Apr 7, 2023 · 11 shares · 40,798 followers View post →
Debby Keller, MD
@debby_keller · X

RT @escp_tweets: Response to neoadjuvant #chemotherapy will potentially be used as a marker to decide who needs adjuvant therapy after surg…

Apr 7, 2023 · 11 shares · 7,131 followers View post →
ZoeGaroufalia
@ZGaroufalia · X

RT @escp_tweets: Response to neoadjuvant #chemotherapy will potentially be used as a marker to decide who needs adjuvant therapy after surg…

Apr 7, 2023 · 11 shares · 1,658 followers View post →
Jamshed Shabbir
@jshabbir · X

RT @escp_tweets: Response to neoadjuvant #chemotherapy will potentially be used as a marker to decide who needs adjuvant therapy after surg…

Apr 7, 2023 · 11 shares · 417 followers View post →
Zahira_GC
@GcZahira · X

RT @escp_tweets: Response to neoadjuvant #chemotherapy will potentially be used as a marker to decide who needs adjuvant therapy after surg…

Apr 7, 2023 · 11 shares · 783 followers View post →
European Society of Coloproctology
@escp_tweets · X

Response to neoadjuvant #chemotherapy will potentially be used as a marker to decide who needs adjuvant therapy after surgery.  Read more about the FOxTROT Study at the #ESCP website: https://t.co/S49EgSVatB Or read the paper: https://t.co/4Hrnsm3Gn4 #ColonCancer #SoMe4Surgery https://t.co/qMgMio4NiE

Apr 7, 2023 · 17 likes · 11 shares · 14,949 followers View post →
Joel YR
@YnfaYr · X

RT @JenSeligmann:

Apr 6, 2023 · 133 shares · 116 followers View post →
John Monson MD FRCS FACS FASCRS
@JohnRTMonsonMD · X

RT @escp_tweets: Another benefit of the FOxTROT study is that we saw that patients with MMRd do not respond to neoadjuvant chemo, but actua…

Apr 5, 2023 · 14 shares · 5,490 followers View post →
Vanessa Bettencourt
@Vbettencourt83 · X

RT @escp_tweets: Another benefit of the FOxTROT study is that we saw that patients with MMRd do not respond to neoadjuvant chemo, but actua…

Apr 5, 2023 · 14 shares · 260 followers View post →
ErmanAytac
@DrErmanAytac · X

RT @escp_tweets: Another benefit of the FOxTROT study is that we saw that patients with MMRd do not respond to neoadjuvant chemo, but actua…

Apr 5, 2023 · 14 shares · 1,875 followers View post →
Sameh Emile, MD, FACS
@dr_samehhany81 · X

RT @escp_tweets: Another benefit of the FOxTROT study is that we saw that patients with MMRd do not respond to neoadjuvant chemo, but actua…

Apr 5, 2023 · 14 shares · 2,847 followers View post →
Eloy Espín
@eloiespin · X

RT @escp_tweets: Another benefit of the FOxTROT study is that we saw that patients with MMRd do not respond to neoadjuvant chemo, but actua…

Apr 5, 2023 · 14 shares · 3,379 followers View post →
Zahira_GC
@GcZahira · X

RT @escp_tweets: Another benefit of the FOxTROT study is that we saw that patients with MMRd do not respond to neoadjuvant chemo, but actua…

Apr 5, 2023 · 14 shares · 783 followers View post →
Debby Keller, MD
@debby_keller · X

RT @escp_tweets: Another benefit of the FOxTROT study is that we saw that patients with MMRd do not respond to neoadjuvant chemo, but actua…

Apr 5, 2023 · 14 shares · 7,131 followers View post →
Rubiel E
@JeaBattle · X

RT @escp_tweets: Another benefit of the FOxTROT study is that we saw that patients with MMRd do not respond to neoadjuvant chemo, but actua…

Apr 5, 2023 · 14 shares · 614 followers View post →
Carlo Brugiotti
@cbrug76 · X

RT @escp_tweets: Another benefit of the FOxTROT study is that we saw that patients with MMRd do not respond to neoadjuvant chemo, but actua…

Apr 5, 2023 · 14 shares · 194 followers View post →
Nicolas Avellaneda
@nlavellaneda · X

RT @escp_tweets: Another benefit of the FOxTROT study is that we saw that patients with MMRd do not respond to neoadjuvant chemo, but actua…

Apr 5, 2023 · 14 shares · 2,485 followers View post →
European Society of Coloproctology
@escp_tweets · X

Another benefit of the FOxTROT study is that we saw that patients with MMRd do not respond to neoadjuvant chemo, but actually need immunotherapy.  Find out more: https://t.co/w5wr5KADCK Read the paper: https://t.co/wegcXAtvRl #SoMe4Surgery #ColonCancer #ColorectalSurgery https://t.co/xGsqJFMB2o

Apr 5, 2023 · 21 likes · 14 shares · 14,949 followers View post →
UMASS Colorectal Surgery
@UMASSColorectal · X

This RCT evaluated the impact of providing 6 weeks of neoadjuvant chemotherapy + 18 postoperatively instead of the standard 24 weeks of postoperative chemotherapy for those with locally advanced #ColonCancer @justinmaykel @KarimAlavi @TessAulet @PRSturrock https://t.co/NVdhWQlNBW

Mar 30, 2023 · 2 likes · 582 followers View post →
CU GITES
@cugites · X

RT @CamilleLStewart: Amazing how much things change over time in surgical oncology! Colorectal friends, are your T3/T4 colon cancer pts get…

Mar 23, 2023 · 1 share · 506 followers View post →
Camille Stewart, MD
@CamilleLStewart · X

Amazing how much things change over time in surgical oncology! Colorectal friends, are your T3/T4 colon cancer pts getting pre-op chemo now? https://t.co/uBY4QI1FSm

Mar 16, 2023 · 2 likes · 1 share · 1,065 followers View post →
د.عبدالله علي الشرم
@dralsharm · X

RT @saadvikdr:

Mar 15, 2023 · 5 shares · 3,961 followers View post →
Mrugal Doshi
@mrugaldoshi · X

RT @ArndtVogel:

Mar 14, 2023 · 21 shares · 55 followers View post →
Elene Mariamidze
@EMariamidze · X

RT @saadvikdr:

Mar 14, 2023 · 5 shares · 2,464 followers View post →
Dr. Shashank Joshi
@AskDrShashank · X

RT @saadvikdr:

Mar 13, 2023 · 5 shares · 32,534 followers View post →
Hemanth Kumar
@drhemanthmd1 · X

RT @saadvikdr:

Mar 13, 2023 · 5 shares · 958 followers View post →
OncoAlert
@OncoAlert · X

RT @saadvikdr:

Mar 13, 2023 · 5 shares · 39,854 followers View post →
Dr. Saadvik Raghuram y
@saadvikdr · X

Mar 13, 2023 · 16 likes · 5 shares · 704 followers View post →
Reza Ghalehtaki
@RGhalehtaki · X

RT @JenSeligmann:

Mar 13, 2023 · 133 shares · 315 followers View post →
Cihan Gani
@GI_RadOnc · X

Mar 12, 2023 · 13 likes · 5 shares · 1,392 followers View post →
drfeelgood
@drfeelgood049 · X

RT @gabe_a_brooks: FoxTROT is a great and highly pragmatic study. Shows that we don't always need new drugs to learn new things in cancer t…

Mar 11, 2023 · 2 shares · 128 followers View post →
Rodrigo Mariano
@RmarianoMariano · X

RT @ArndtVogel:

Mar 11, 2023 · 21 shares · 129 followers View post →
Dr Joseph McCollom DO
@realbowtiedoc · X

RT @gabe_a_brooks: FoxTROT is a great and highly pragmatic study. Shows that we don't always need new drugs to learn new things in cancer t…

Mar 11, 2023 · 2 shares · 3,578 followers View post →
José M Peñaloza
@maur_jmp · X

RT @ArndtVogel:

Mar 11, 2023 · 21 shares · 361 followers View post →
Encarna González Flo
@flo_encarna · X

RT @ArndtVogel:

Mar 10, 2023 · 21 shares · 485 followers View post →
摘星012
@tcm0318 · X

RT @ArndtVogel:

Mar 10, 2023 · 21 shares · 28 followers View post →
filippo masini
@filimasini · X

RT @ArndtVogel:

Mar 10, 2023 · 21 shares · 770 followers View post →
Gabriel Brooks
@gabe_a_brooks · X

FoxTROT is a great and highly pragmatic study. Shows that we don't always need new drugs to learn new things in cancer treatment. New drugs are great, but I love to see new studies that unlock better ways to use old drugs. https://t.co/Av6B9QBqr5

Mar 10, 2023 · 16 likes · 2 shares · 1,948 followers View post →
Ricard Borrás Ferreres
@borras_ricard · X

RT @ArndtVogel:

Mar 10, 2023 · 21 shares · 111 followers View post →
Debby Keller, MD
@debby_keller · X

RT @ArndtVogel:

Mar 10, 2023 · 21 shares · 7,131 followers View post →
henryvargas
@henryva08402477 · X

RT @ArndtVogel:

Mar 10, 2023 · 21 shares · 36 followers View post →
Eduard Centeno
@segol60 · X

RT @ArndtVogel:

Mar 10, 2023 · 21 shares · 409 followers View post →
Stefan Zilli
@stefan_zilli · X

RT @ArndtVogel:

Mar 10, 2023 · 21 shares · 84 followers View post →
Santhosh Ambika
@RenoHemonc · X

RT @ArndtVogel:

Mar 9, 2023 · 21 shares · 4,017 followers View post →
Kelly Araujo
@KellyBorgesAra2 · X

RT @ArndtVogel:

Mar 9, 2023 · 21 shares · 217 followers View post →
Alan Reyes-M.D
@dralanreyesonco · X

RT @ArndtVogel:

Mar 9, 2023 · 21 shares · 1,350 followers View post →
Julio Betiol
@Julhao_03 · X

RT @ArndtVogel:

Mar 9, 2023 · 21 shares · 85 followers View post →
Marco A
@aurelioassad · X

RT @ArndtVogel:

Mar 9, 2023 · 21 shares · 155 followers View post →
Basel Shoua
@Baselsho · X

RT @ArndtVogel:

Mar 9, 2023 · 21 shares · 267 followers View post →
Davide Ciardiello
@DCiardiello · X

RT @ArndtVogel:

Mar 9, 2023 · 21 shares · 472 followers View post →
Neeraj Chouhan
@chouhanneeraj07 · X

RT @ArndtVogel:

Mar 9, 2023 · 21 shares · 783 followers View post →
Arndt Vogel
@ArndtVogel · X

Mar 9, 2023 · 54 likes · 21 shares · 8,659 followers View post →
@investigando
@rocatanho · X

6 sem de QT preoperatoria c/oxaliplatino-fluoropirimidina para CA colon operable no aumenta morbilidad perioperatoria, reduciendo estadificación histopatológica y resecciones incompletas y mejor control a los 2 años #colon #cancer #QT https://t.co/1M8J0nvvHH

Mar 9, 2023 · 400 followers View post →
עידו וולף
@IdoWolf1 · X

יתרון לטיפול אונקולוגי לפני ניתוח- כעת גם בסרטן מעי גס. הצהרה פרובוקטיבית לחברים מפיד רפואה: All T3-4 or N+ tumors should get neoadjuvant therapy regardless of their origin https://t.co/clqBJobTnx

Mar 8, 2023 · 16 likes · 11,491 followers View post →
Ido Wolf
@IdoWolf5 · X

It seems that all T3-4 or N+ tumors should get neoadjuvant regardless of their origin! https://t.co/TsmD55k6gu

Mar 8, 2023 · 128 followers View post →
INDoximity
@indoximity · X

Preoperative Chemotherapy for Operable Colon Cancer: Mature Results of an International Randomized Controlled Trial https://t.co/UzzRrUU0zz #Oncology

Mar 8, 2023 · 831 followers View post →
EDGAR ANDRES PULIDO
@edgarpugil · X

RT @JenSeligmann:

Feb 26, 2023 · 133 shares · 28 followers View post →
Anupriya Agarwal
@anupriyaa · X

RT @JenSeligmann:

Feb 23, 2023 · 133 shares · 169 followers View post →
Chris Varghese
@chrisvarghese98 · X

RT @EuroSurg: Exciting to see #FOxTROT 1 published: https://t.co/C2i4X6bnk3 #APOLLO collecting important data on: - how many acutely prese…

Feb 15, 2023 · 1 share · 965 followers View post →
Luis Rodriguez
@lurodme · X

RT @FoxtrotStudy: Interested? Please do download and share the full paper!

Feb 10, 2023 · 6 shares · 429 followers View post →
Filippo Pietrantonio
@FilippoPietran4 · X

RT @JCO_ASCO: Preoperative chemotherapy for operable #ColonCancer in the @FoxtrotStudy is safe and yields: ⬆️ histopathologic downstaging…

Feb 7, 2023 · 12 shares · 1,342 followers View post →
Victor Bundi.
@huncho_vic · X

RT @JCO_ASCO: Preoperative chemotherapy for operable #ColonCancer in the @FoxtrotStudy is safe and yields: ⬆️ histopathologic downstaging…

Feb 7, 2023 · 12 shares · 203 followers View post →
International Cancer Institute
@Intercancer · X

RT @JCO_ASCO: Preoperative chemotherapy for operable #ColonCancer in the @FoxtrotStudy is safe and yields: ⬆️ histopathologic downstaging…

Feb 7, 2023 · 12 shares · 1,935 followers View post →
OncoAlert
@OncoAlert · X

RT @JCO_ASCO: Preoperative chemotherapy for operable #ColonCancer in the @FoxtrotStudy is safe and yields: ⬆️ histopathologic downstaging…

Feb 7, 2023 · 12 shares · 39,854 followers View post →
Journal of Clinical Oncology
@JCO_ASCO · X

Preoperative chemotherapy for operable #ColonCancer in the @FoxtrotStudy is safe and yields: ⬆️ histopathologic downstaging

Feb 7, 2023 · 33 likes · 12 shares · 54,542 followers View post →
Will Loughborough
@LoughboroughW · X

Preoperative Chemotherapy for Operable Colon Cancer: Mature Results of an International Randomized Controlled Trial https://t.co/DDAzzarfne

Feb 4, 2023 · 687 followers View post →
Francesco Vitali
@Frances87813521 · X

Preoperative Chemotherapy for Operable Colon Cancer: Mature Results of an International RCT https://t.co/wtldq7RRBc What Do you think about it? What about EGFR Inhibition in RAS-wt preoperative? Interesting development of knowledge. Congratulations! @ArndtVogel

Feb 4, 2023 · 17 followers View post →
Nancy Stephen Matowo
@NancyStephen1 · X

RT @Fredros_Inc: By splitting colon cancer patients’ chemotherapy into two parts — one delivered before surgery and one after it — European…

Jan 30, 2023 · 1 share · 295 followers View post →
Fredros Okumu
@Fredros_Inc · X

By splitting colon cancer patients’ chemotherapy into two parts — one delivered before surgery and one after it — European researchers reduced their risk of recurrence by 28% compared to patients who received all of their chemo after surgery. https://t.co/eVqII3YkDE

Jan 30, 2023 · 1 like · 1 share · 15,498 followers View post →
RAH Colorectal Research Group
@RAHcolorectal · X

RT @JenSeligmann:

Jan 29, 2023 · 133 shares · 570 followers View post →
ilyas sahin, MD
@ilyassahinMD · X

7- Referans: https://t.co/FNMR8Na7JE

Jan 28, 2023 · 5 likes · 20,808 followers View post →
A/Prof Tim Clay
@drtclay · X

@JCO_ASCO #crcsm FOxTROT randomised between NAC (periop chemo) and standard adjuvant in T3-4N0-2M0 CRC 1,053 (41%) of 2,591 were randomized - granularity on what happened to the 59% who weren't randomized would be helpful to place this trial in context https://t.co/0oCWITauxQ

Jan 28, 2023 · 1,720 followers View post →
ASCO
@ASCO · X

RT @JCO_ASCO:

Jan 27, 2023 · 5 shares · 149,457 followers View post →
Journal of Clinical Oncology
@JCO_ASCO · X

Jan 27, 2023 · 15 likes · 5 shares · 54,542 followers View post →
A.n.n.
@fireflyann · X

RT @JenSeligmann:

Jan 26, 2023 · 133 shares · 1,580 followers View post →
Rafael Correa Cano MD, MSc.
@Rf_Correa · X

RT @JenSeligmann:

Jan 26, 2023 · 133 shares · 1,008 followers View post →
R&D at SWFT
@Research_SWFT · X

RT @CancerWarwick: The primary results for #FOxTROT have been published. Preoperative chemotherapy for locally advanced colon cancer is wel…

Jan 26, 2023 · 1 share · 351 followers View post →
Dr.M Khan
@DrManzoorKhan1 · X

RT @JenSeligmann:

Jan 25, 2023 · 133 shares · 585 followers View post →
Kashish Shah
@kashishshah99 · X

RT @JenSeligmann:

Jan 25, 2023 · 133 shares · 2,136 followers View post →
Jp Solar Vasconcelos
@jaypsv · X

RT @polom_karol: #Preoperative Chemotherapy for Operable #ColonCancer: Mature Results of an International #RandomizedControlledTrial https:…

Jan 25, 2023 · 2 shares · 679 followers View post →
Oncology Brothers
@OncBrothers · X

RT @JenSeligmann:

Jan 25, 2023 · 133 shares · 18,857 followers View post →
NIHR_GSU_lagoshub
@nihr_gsu_lhub · X

Published Paper! The primary FOxTROT1 paper, "Preoperative chemotherapy for operable colon cancer: mature results of an international randomised controlled trial has been published. Check the paper on the JCO website at https://t.co/P3JUlOqYuV (Open-access, free-to-view).

Jan 25, 2023 · 3 likes · 192 followers View post →
Arjun Jeganathan, MD, FACS, FASCRS
@arjunjeg · X

RT @JenSeligmann:

Jan 24, 2023 · 133 shares · 271 followers View post →
Thales P. Batista, MD, PhD
@BatistaTP · X

RT @polom_karol: #Preoperative Chemotherapy for Operable #ColonCancer: Mature Results of an International #RandomizedControlledTrial https:…

Jan 24, 2023 · 2 shares · 1,284 followers View post →
En Cheng
@EnCheng23 · X

RT @JenSeligmann:

Jan 24, 2023 · 133 shares · 276 followers View post →
Karol Polom
@polom_karol · X

#Preoperative Chemotherapy for Operable #ColonCancer: Mature Results of an International #RandomizedControlledTrial https://t.co/vlXwuRwzgb @JCOGO_ASCO

Jan 24, 2023 · 3 likes · 2 shares · 1,220 followers View post →
Gastrosurgery Kairaluoma Oy
@GsKairaluomaOy · X

Preoperative Chemotherapy for Operable Colon Cancer: Mature Results of an International Randomized Controlled Trial https://t.co/zr103v6VQu

Jan 24, 2023 · 5 followers View post →
katie morris
@kt2morris · X

RT @BhamCTU: FOxTROT-1 trial results have been released by @JCO_ASCO! ✅Pre-operative chemotherapy for locally advanced operable colon canc…

Jan 23, 2023 · 2 shares · 1,933 followers View post →
Faheez Mohamed
@FaheezM · X

Better disease control at 2 years with neo adjuvant chemo for advanced colorectal cancer. Preoperative Chemotherapy for Operable Colon Cancer: Mature Results of an International Randomized Controlled Trial | Journal of Clinical Oncology https://t.co/LSijN1HJub

Jan 21, 2023 · 8 likes · 946 followers View post →
Rod Alexander
@MrRodalexander · X

RT @RMirnezami: Preoperative Chemotherapy for Operable Colon Cancer: Mature Results of an International Randomized Controlled Trial https:/…

Jan 21, 2023 · 6 shares · 275 followers View post →
Stigmabase | NORTH
@StigmabaseN · X

TW : Preoperative Chemotherapy for Operable Colon Cancer: Mature Results of an International Randomized...: PRIOR PRESENTATIONPresented in part at the 2019 ASCO annual meeting, Chicago, IL, May 31-June 4, 2019.FOxTROT was funded by Cancer Research UK… https://t.co/w9z5AFR7nM

Jan 20, 2023 · 1,745 followers View post →
Mahmoud Abdeldayem
@MA_Abdeldayem · X

Preoperative Chemotherapy for Operable Colon Cancer: Mature Results of an International Randomized Controlled Trial | Journal of Clinical Oncology https://t.co/kVWm1IeB2n

Jan 20, 2023 · 1 like · 154 followers View post →
Dr I Malik
@malikkotli · X

Preoperative Chemotherapy for Operable Colon Cancer: Mature Results of an International Randomized Controlled Trial | Journal of Clinical Oncology https://t.co/nK5HferaQc

Jan 20, 2023 · 89 followers View post →
Paul Ziprin
@PaulZiprin · X

Preoperative Chemotherapy for Operable Colon Cancer: Mature Results of an International Randomized Controlled Trial | Journal of Clinical Oncology https://t.co/tSm7KisGr3

Jan 20, 2023 · 1 like · 411 followers View post →
Juan Quirós
@kiriki221 · X

RT @RyanNipp: Preoperative Chemotherapy for Operable Colon #Cancer: Mature Results of an International Randomized Controlled Trial. https…

Jan 20, 2023 · 4 shares · 296 followers View post →
Joanne Dale
@DrJoDale · X

RT @RMirnezami: Preoperative Chemotherapy for Operable Colon Cancer: Mature Results of an International Randomized Controlled Trial https:/…

Jan 20, 2023 · 6 shares · 449 followers View post →
DrNeirax
@JorgeINeira1 · X

RT @RMirnezami: Preoperative Chemotherapy for Operable Colon Cancer: Mature Results of an International Randomized Controlled Trial https:/…

Jan 20, 2023 · 6 shares · 340 followers View post →
Cancer Library VCC
@VCCLibrary · X

Preoperative Chemotherapy for Operable Colon #Cancer: Mature Results of an International Randomized Controlled Trial https://t.co/QuAbgXB9Ac

Jan 20, 2023 · 1,280 followers View post →
James Glasbey
@DrJamesGlasbey · X

RT @BhamCTU: FOxTROT-1 trial results have been released by @JCO_ASCO! ✅Pre-operative chemotherapy for locally advanced operable colon canc…

Jan 20, 2023 · 2 shares · 5,064 followers View post →
Birmingham Clinical Trials Unit
@BhamCTU · X

FOxTROT-1 trial results have been released by @JCO_ASCO! ✅Pre-operative chemotherapy for locally advanced operable colon cancer is safe ✅Improved histopathological & oncological outcomes ✅Reduced 2-year recurrence https://t.co/d5Due1ohJU

Jan 20, 2023 · 6 likes · 2 shares · 1,126 followers View post →
×SymphonicSc4lpel×™
@throwingscalpel · X

RT @RMirnezami: Preoperative Chemotherapy for Operable Colon Cancer: Mature Results of an International Randomized Controlled Trial https:/…

Jan 20, 2023 · 6 shares · 118 followers View post →
Nicolas Avellaneda
@nlavellaneda · X

RT @NIHR_GSU: You can now view our primary FOxTROT1 paper: "Preoperative chemotherapy for operable colon cancer: mature results of an inter…

Jan 20, 2023 · 3 shares · 2,485 followers View post →
@Some4SurgeryITeam
@Some4SurgeryIT1 · X

RT @RMirnezami: Preoperative Chemotherapy for Operable Colon Cancer: Mature Results of an International Randomized Controlled Trial https:/…

Jan 20, 2023 · 6 shares · 5,474 followers View post →
Faraz Khan
@FarazKh65499316 · X

RT @RMirnezami: Preoperative Chemotherapy for Operable Colon Cancer: Mature Results of an International Randomized Controlled Trial https:/…

Jan 20, 2023 · 6 shares · 1,739 followers View post →
Reza Mirnezami
@RMirnezami · X

Preoperative Chemotherapy for Operable Colon Cancer: Mature Results of an International Randomized Controlled Trial https://t.co/alnW7P3f2O

Jan 20, 2023 · 9 likes · 6 shares · 1,232 followers View post →
Bob O'Mara
@TheBigGuyO · X

RT @RyanNipp: Preoperative Chemotherapy for Operable Colon #Cancer: Mature Results of an International Randomized Controlled Trial. https…

Jan 19, 2023 · 4 shares · 54 followers View post →
Cashprize
@Cashprize · X

RT @RyanNipp: Preoperative Chemotherapy for Operable Colon #Cancer: Mature Results of an International Randomized Controlled Trial. https…

Jan 19, 2023 · 4 shares · 315 followers View post →
Michael Fisch MD MPH
@fischmd · X

RT @RyanNipp: Preoperative Chemotherapy for Operable Colon #Cancer: Mature Results of an International Randomized Controlled Trial. https…

Jan 19, 2023 · 4 shares · 20,308 followers View post →
Ryan Nipp, MD, MPH, MBA, FASCO
@RyanNipp · X

Preoperative Chemotherapy for Operable Colon #Cancer: Mature Results of an International Randomized Controlled Trial. https://t.co/lutohxTwy2 #GI23 #ColonCancer @ASCO @JCO_ASCO https://t.co/fSf8cItgCB

Jan 19, 2023 · 18 likes · 4 shares · 4,548 followers View post →
Unidad de Coloproctología del HUGetafe
@ColonGetafe · X

RT @NIHR_GSU: You can now view our primary FOxTROT1 paper: "Preoperative chemotherapy for operable colon cancer: mature results of an inter…

Jan 19, 2023 · 3 shares · 1,185 followers View post →
Medical Xpress
@physorg_health · X

Chemotherapy before #surgery cuts risk of #coloncancer returning, trial finds https://t.co/VkExLRiGaj https://t.co/ieT7UcQeXN

Jan 19, 2023 · 1 like · 7,106 followers View post →
EAGLE Study
@EagleEscp · X

RT @NIHR_GSU: You can now view our primary FOxTROT1 paper: "Preoperative chemotherapy for operable colon cancer: mature results of an inter…

Jan 19, 2023 · 3 shares · 1,271 followers View post →
NIHR Global Surgery
@NIHR_GSU · X

You can now view our primary FOxTROT1 paper: "Preoperative chemotherapy for operable colon cancer: mature results of an international randomised controlled trial" on the @ASCO website. You can view the paper via the below link: https://t.co/hkYjPGRUvB

Jan 19, 2023 · 9 likes · 3 shares · 4,339 followers View post →